Cirrus Therapeutics
Latest round
- Seed
Last raised
- Aug 2026
Total raised
- $15M
Investors
- 5
About Cirrus Therapeutics
Founded in 2023 and based in Massachusetts, US, by CEO Ying Kai Chan and co-founder Andrew Dick, Cirrus Therapeutics Inc. operates as a biotech company providing solution for chronic blinding diseases treating the ocular immune system. In August 2026, Cirrus Therapeutics Inc. Cirrus Therapeutics Inc. develops treatments for long-term eye diseases that can cause blindness, focusing on conditions that affect the ocular immune system.
Who invested in Cirrus Therapeutics
5 investors across 2 rounds
See all investors in Cirrus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cirrus Therapeutics
Who invested in Cirrus Therapeutics?
Cirrus Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cirrus Therapeutics raised?
Cirrus Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cirrus Therapeutics last raise money?
Cirrus Therapeutics's most recent round on record is a Seed, in Aug 2026.
What does Cirrus Therapeutics do?
Founded in 2023 and based in Massachusetts, US, by CEO Ying Kai Chan and co-founder Andrew Dick, Cirrus Therapeutics Inc.
Where is Cirrus Therapeutics headquartered?
Cirrus Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Cirrus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cirrus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cirrus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.